FFCP PHASE1:Hg19::chr17:59322564..59322600,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=54828 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=14347 | |||
|TSSclassifier=weak | |||
|UniProt= | |||
|association_with_transcript=0bp_to_uc002izc.3_5end | |||
|coexpression_cluster_id=C169 | |||
|description=CAGE_peak_5_at_BCAS3_5end | |||
|id=chr17:59322564..59322600,+ | |||
|ontology_enrichment_celltype=CL:0000945!8.21e-21!24;CL:0000826!8.21e-21!24;CL:0000838!5.14e-16!52;CL:0000542!1.14e-15!53;CL:0000051!1.14e-15!53;CL:0000785!5.44e-14!2;CL:0000955!5.44e-14!2;CL:0000818!5.44e-14!2;CL:0000954!5.44e-14!2;CL:0000816!5.44e-14!2;CL:0002087!9.29e-11!119;CL:0002031!3.36e-10!124;CL:0000817!1.26e-09!3;CL:0000039!9.08e-09!7;CL:0000586!9.08e-09!7;CL:0000738!1.10e-08!140;CL:0000946!4.07e-08!1;CL:0000786!4.07e-08!1;CL:0000980!4.07e-08!1;CL:0002032!5.23e-08!165;CL:0000837!5.23e-08!165;CL:0000819!1.44e-07!1;CL:0000037!1.51e-07!172;CL:0000566!1.51e-07!172;CL:0000988!5.92e-07!182 | |||
|ontology_enrichment_celltype_v019=CL:0000946;3.28e-23;1!CL:0000786;3.28e-23;1!CL:0000945;4.18e-15;24!CL:0000542;1.85e-08;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,4.10e-23,1;CL:0000786,4.10e-23,1;CL:0000980,4.10e-23,1;CL:0000838,2.97e-15,52;CL:0000945,4.11e-15,24;CL:0000826,4.11e-15,24;CL:0000542,5.75e-15,53;CL:0000051,5.75e-15,53;CL:0000785,2.90e-12,2;CL:0000955,2.90e-12,2;CL:0000818,2.90e-12,2;CL:0000954,2.90e-12,2;CL:0000816,2.90e-12,2;CL:0000817,1.30e-08,3;CL:0002087,8.19e-07,115 | |||
|ontology_enrichment_development_v019=CL:0000954;2.59e-12;2!CL:0000051;1.85e-08;53 | |||
|ontology_enrichment_disease=DOID:0060058!3.44e-23!10;DOID:2355!2.70e-08!1;DOID:0060073!1.44e-07!1;DOID:8675!1.44e-07!1;DOID:2531!3.54e-07!51;DOID:0060083!3.54e-07!51 | |||
|ontology_enrichment_disease_v019=DOID:0060058;2.66e-35;10!DOID:2355;1.19e-23;1!DOID:74;1.56e-12;2!DOID:1909;1.56e-12;2!DOID:2531;1.16e-10;51!DOID:0060083;1.16e-10;51!DOID:1287;6.68e-07;4 | |||
|ontology_enrichment_disease_v019_2=DOID:0060058,2.33e-35,10;DOID:2355,1.07e-23,1;DOID:2531,1.46e-15,51;DOID:0060083,1.46e-15,51;DOID:74,1.48e-12,2;DOID:1909,1.65e-12,2;DOID:1287,6.50e-07,4 | |||
|ontology_enrichment_uberon=UBERON:0000473!9.93e-08!8 | |||
|ontology_enrichment_uberon_v019=UBERON:0002106;1.46e-08;3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002106,1.51e-08,3;UBERON:0004854,1.51e-08,3;UBERON:0009034,1.51e-08,3;UBERON:0002095,1.51e-08,3;UBERON:0004782,1.51e-08,3;UBERON:0003281,1.51e-08,3;UBERON:0009664,1.51e-08,3;UBERON:0002296,1.51e-08,3;UBERON:0005602,1.51e-08,3;UBERON:0001179,1.51e-08,3;UBERON:0006293,1.51e-08,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.458480434487708,0.328402357799783,0.472264687882075,0,0,0,0,0,0,0.0774672005803016,0,0,0,0,0,0,0,0,0,0,0,0,0.411167888021826,0.309706370895104,0,0,0,0,0,0,0.188242339542605,0,0,0,0,0,0,0,0,0.290209238628584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.32592226663359,0,0,0,0,0.221533894583621,0.270803863765016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121973706129595,0,0,0.10366105501537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102827492703324,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.38864302868605,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.89453753271713,0,0,0,0,0,0,0,0,0,0,0,0,0,2.46169610922139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.182454789215666,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.99485973130698,0,0,0,0,0,0,0,0,0,0,0,0,0,6.5198465690654,0,0,0,0.137539436597234,0.415440338029185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.9230223611415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.06596470166591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.41991373867136,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23248285073625,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.39917618294901,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.305966489225945,0,0.18378979906969,0.250707539292375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201273793591026,0 | |||
|short_description=p5@BCAS3 | |||
}} |
Revision as of 16:40, 20 January 2014
Short description: | p5@BCAS3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_5_at_BCAS3_5end |
Coexpression cluster: | C169_hereditary_adult_gall_lymphangiectasia_chronic_b_choriocarcinoma |
Association with transcript: | 0bp_to_uc002izc.3_5end |
EntrezGene: | BCAS3 |
HGNC: | 14347 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 4.10e-23 | 1 |
plasma cell | 4.10e-23 | 1 |
plasmablast | 4.10e-23 | 1 |
lymphoid lineage restricted progenitor cell | 2.97e-15 | 52 |
lymphocyte of B lineage | 4.11e-15 | 24 |
pro-B cell | 4.11e-15 | 24 |
lymphocyte | 5.75e-15 | 53 |
common lymphoid progenitor | 5.75e-15 | 53 |
mature B cell | 2.90e-12 | 2 |
pre-B-II cell | 2.90e-12 | 2 |
transitional stage B cell | 2.90e-12 | 2 |
small pre-B-II cell | 2.90e-12 | 2 |
immature B cell | 2.90e-12 | 2 |
precursor B cell | 1.30e-08 | 3 |
nongranular leukocyte | 8.19e-07 | 115 |
Ontology term | p-value | n |
---|---|---|
spleen | 1.51e-08 | 3 |
gastrointestinal system mesentery | 1.51e-08 | 3 |
stomach region | 1.51e-08 | 3 |
mesentery | 1.51e-08 | 3 |
gastrointestinal system serosa | 1.51e-08 | 3 |
mesentery of stomach | 1.51e-08 | 3 |
gut mesentery | 1.51e-08 | 3 |
dorsal mesentery | 1.51e-08 | 3 |
dorsal mesogastrium | 1.51e-08 | 3 |
peritoneal cavity | 1.51e-08 | 3 |
spleen primordium | 1.51e-08 | 3 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 2.33e-35 | 10 |
anemia | 1.07e-23 | 1 |
hematologic cancer | 1.46e-15 | 51 |
immune system cancer | 1.46e-15 | 51 |
hematopoietic system disease | 1.48e-12 | 2 |
melanoma | 1.65e-12 | 2 |
cardiovascular system disease | 6.50e-07 | 4 |